Life Science

Description : 5-Bromo-2,4-dimethoxybenzoic acid (CAS No: 32246-20-1) is a highly specialized brominated aromatic building block that plays a vital functional role in organic synthesis, particularly as a key intermediate in the structural development of bioactive compounds, neuropharmaceuticals targeting dopamine receptors, and targeted therapeutic candidates such as Veralipride. The regioselective positioning of its methoxy and bromo substituents on the benzoic acid core provides distinct electronic and steric characteristics, making it exceptionally valuable for palladium-catalysed cross-coupling reactions, directed functional group transformations, and advanced custom synthesis projects across the Contract Development and Manufacturing Organisation (CDMO) landscape. Current commercial interest in this disubstituted aromatic derivative is driven by its expanding utility in fine chemical synthesis and agrochemical active ingredient research, where its structural stability and predictable reactivity allow for efficient pathway optimization in scalable multi-step processes. We are an globally established 5-Bromo-2,4-dimethoxybenzoic acid intermediates supplier with >= 99% purity, ensuring minimal carry-over of impurities in the final API, and a broad range of various pharmaceutical intermediates for API manufacturers and finished formulators, providing comprehensive analytical (HPLC/NMR/MS) and supporting 5-Bromo-2,4-dimethoxybenzoic acid COA/TDS/SDS region-specific regulatory support. Beyond supply, we support partners through the entire product lifecycle from route scouting, process and formulation development, pilot-to-commercial manufacturing. Our teams also assist with GMP-compliant quality assurance, regulatory documentation, and global supply chain and logistics coordination.